Latest News of PULM
Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results
By Yahoo! Finance |
2 weeks ago
Pulmonx Corporation's latest quarterly results showed a 4.0% increase in shares, with revenues meeting expectations and losses per share better than expected. Analysts predict a 23% revenue growth in ...
Airway Therapeutics to trial drug for bronchopulmonary dysplasia in newborn babies
By Yahoo! Finance |
1 month ago
Airway Therapeutics, a US biotech company, will conduct a Phase III trial of zelpultide alfa to prevent bronchopulmonary dysplasia in preterm infants. The drug aims to replace a critical lung protein ...
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
By Yahoo! Finance |
2 months ago
Bayer received $14 million upfront for mosliciguat, a lung-targeted sGC activator. Pulmovant presented promising Phase 1b data at the ERS Congress. The drug showed significant reductions in pulmonary ...
-
Bridge Biotherapeutics enrols all subjects in idiopathic pulmonary fibrosis drug trial
By Yahoo! Finance | 3 months agoBridge Biotherapeutics has completed enrollment for a Phase II trial of BBT-877, an autotoxin inhibitor for idiopathic pulmonary fibrosis. The study aims to evaluate efficacy, safety, and tolerability...
-
TGH enters partnership to enhance pulmonary care in Florida, US
By Yahoo! Finance | 4 months agoTampa General Hospital partners with Pulmonary, Critical Care & Sleep Disorders Institute in South Florida to expand services in Palm Beach County. The institute will now operate as TGH Pulmonary Care...